Adenosquamous Carcinoma of the Lung

EGFR fluorescence in situ hybridization-positive lung adenocarcinoma: incidence of coexisting KRAS and BRAF mutations

(2010) Simion Chiosea et al.   HUMAN PATHOLOGY

Using Whole Genome Amplification (WGA) of Low-Volume Biopsies to Assess the Prognostic Role of EGFR, KRAS, p53, and CMET Mutations in Advanced-Stage Non-small Cell Lung Cancer (NSCLC)

(2010) Elaine H. Lim et al.   Journal of Thoracic Oncology

Epidermal growth factor receptor inhibitors in cancer treatment: advances, challenges and opportunities

(2009) Helmout Modjtahedi et al.   ANTI-CANCER DRUGS

Molecular characterization of EGFR, PDGFRA and VEGFR2 in cervical adenosquamous carcinoma

(2009) Adhemar Longatto-Filho et al.   BMC CANCER

Adenosquamous carcinoma of the pancreas harbors KRAS2, DPC4 and TP53 molecular alterations similar to pancreatic ductal adenocarcinoma

(2009) Jonathan R Brody et al.   MODERN PATHOLOGY

Clinicopathological predictors of EGFR/KRAS mutational status in primary lung adenocarcinomas

(2009) Sanja Dacic et al.   MODERN PATHOLOGY

Molecular Characteristics of Bronchioloalveolar Carcinoma and Adenocarcinoma, Bronchioloalveolar Carcinoma Subtype, Predict Response to Erlotinib

(2008) Vincent A. Miller et al.   JOURNAL OF CLINICAL ONCOLOGY

Sequential Molecular Changes during Multistage Pathogenesis of Small Peripheral Adenocarcinomas of the Lung

(2008) Junichi Soh et al.   Journal of Thoracic Oncology